High-net-worth individuals (HNIs) such as Ashish Rameshchandra Kacholia and Artian Investments, a UK-based investment banking firm, invested equity finance of around Rs 225 crore (nearly $27 million) to the biopharmaceutical startup PlasmaGen Biosciences.
![[Funding alert] PlasmaGen Biosciences Secures Rs 225 Cr Equity Investment](https://img-cdn.publive.online/fit-in/580x348/filters:format(webp)/viestories/media/post_attachments/wp-content/uploads/2023/12/PlasmaGen-Biosciences-Secures-Rs-225-Cr-Equity-Investment.webp)